Elcelyx Therapeutics Company
Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.
%20.jpg)
Founded Date:
2010
Total Funding:
$96.8M
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Late Stage Venture
Technology:
Small Molecules
Last Funding Type:
Series E
Investors Number:
6
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M